@mirscientific.com
miRâs Disease Management Platform⢠gives providers and patients first-time access to actionable health data, illuminating a clear path to cancer management.
📢
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
SVG
Icon
JPEG
About
Description
With a commitment to transforming global cancer management, miR Scientific offers the miR Disease Management Platform®, a proprietary and non-invasive platform for effectively managing targeted diseases, initially focusing on urological cancers. At the core of the platform is the miR Sentinel® Prostate Cancer Test, a liquid biopsy urine test that can accurately detect, classify, and monitor prostate cancer by analyzing small-non-coding RNAs extracted from urinary exosomes. With this innovative approach, miR Scientific aims to provide early and highly accurate detection, characterization, and monitoring of diseases.
Led by a team of experienced leaders and scientific experts, miR Scientific is dedicated to revolutionizing cancer management and improving patient outcomes
Company Type
Privately Held
Company Size
51-200
Year Founded
2013
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere 👋
All services online